Life Sciences

Strategic Transaction

Your specialist Life Sciences M&A, Corporate Finance and Capital Sourcing firm

Looking for Life Sciences and Healthcare experts?

Get in touch

Vinc supports Life Sciences companies with strategic consulting and corporate finance advisory services, throughout their entire business cycle. All the way from start-up, via company growth to succession and exit.

Get in touch

Creative strategic advice, persistent execution


Vinc was created in order to help companies active in the Life Sciences industry execute transformational transactions. Through all phases: pre-transaction, transaction, post-transaction. From start-ups to international corporations. With a 100% Life Sciences focus and our dedication to solution orientation, we speak the same language as our clients and act not only as service provider, we become a sparring partner.

Combining independent strategy consulting and financial advisory – Strategic Transaction Advisory.

Customers from all over the world trust our competence in managing the sale and acquisition of companies, products and product portfolios, strategic advice, structuring financings and executing licensing as well as royalty monetization transactions. And we’re there for them, wherever they need us.

We’re really blessed to have found VincAdvisory, as a specialist Life Sciences M&A advisory firm for our European acquisition initiatives. Due to their industry specialization, they immediately understood our business, quickly familiarized themselves with our company and acquisition strategy and helped us in identifying and speaking to the right fit targets. Their entrenchment within the industry and their relationships with small- and medium sized company owners and owner families is unparalleled. Being headquartered in the US, this has been truly helpful to SPX Flow.

Vusa Mlingo
VP Corporate Development & Strategy – SPX FLOW, US

We have been in contact with Thomas and Vinc for more than 5 years, ever since he pro-actively reached out to us. Since then, he has been our gateway to the pharma CRO industry in Europe and our one-stop shop to understand the pharma CRO industry, to identify potential opportunities, to increase our scale and to run the M&A process. Thomas and his team combine a deep knowledge & network with a creative & entrepreneurial mindset to come up with innovative constellations.

Koen de Witte
CEO and Shareholder - reMYND, BE

It was a pleasure working with the teamof Vinc - on the other side(!). Vinc is a very professional organization within-depth industry expertise – top league for mid-market transactions – and haveclearly helped the sellers in the best way.

Gijs Botman
Managing Partner - Mentha Capital, NL

Full range of strategic advisory services for transformational transactions


With Vinc’s holistic advisory approach, we excel in tailor-made and solution oriented project execution, helping our clients to overcome their most challenging issues.

M&A Advisory

Vinc is a leading advisor in sale and carve-out preparation, exit readiness, commercial DD, company and plant sales and acquisitions, joint ventures and strategic alliances, post-merger strategy, buy&build and divestments.

Financial Advisory

We help our clients with tailor-made financial structuring, valuation and fairness opinions, defense strategies, debt financings, equity capital market transactions, project financings, recapitalizations, fundraisings.

Product Advisory

Vinc executes international pre-commercial and commercial-stage licensing transactions, product and product portfolio sales and acquisitions, R&D/patent sales and acquisitions, as well as royalty monetization transactions.

Committee Advisory

We provide independent, special advisory services to company management, shareholders and executive committees with respect to value creation topics, M&A strategies, growth and market entry strategies as well as shareholder relations.

Vinc initially created our transaction with their creativity, knowledge and network. During the challenging and difficult process with several stakeholders, they managed to keep all parties aligned with their accurate, constructive and dedicated process management. It was a pleasure working with Thomas and Stephan and we want to thank them for their support.

Fabian Hendrix
Investment Manager - BOM Brabant Ventures, NL

We were very pleased with the support from Vinc during the entire process of the sale of Inno4Life, especially their ability to manage a complex and international process during the most difficult phases of the transaction. As part of the Dec Group we trust Inno4Life can move forward to the next stages of it growth. Vinc has supported us with a dedicated team and was committed to get the deal done. It was a pleasure working with them.

Jan-Frens van Giessel
Partner Healthcare - Holland Capital, NL

We are impressed by Vinc Advisory’s in-depth knowledge of the CDMO market space. Vinc has allowed us to very quickly understand the target landscape, define priorities and has acted as a sparring partner throughout the process. Their long-standing relationships with key decision makers is a real asset, enabling access to the ownership and management of potential target companies. We are grateful to have Vinc Advisory as a partner for the execution of our M&A strategy.

Head of M&A
European Specialty API Manufacturer, EU

We experienced Vinc to be a highly knowledgeable partner who advised us throughout the transaction process. We highly appreciated their full service: they helped us in many ways from company presentation support over deal negotiation to contract making. Our sincere appreciation to the dedicated team for their professionalism and perseverance.

Dr. Harry Christiaens
CEO and shareholder - Pharmavize, BE

In-depth expertise accross the convergent Life Sciences industry landscape – from molecule to market


Vinc’s unparalleled specialization and long-standing expertise lies particularly within the businesses along the pharmaceutical development chain; besides that, we’re advising clients in the MedTech, Diagnostics and Digital Health space.

Pharma, Biotech and Life Sciences Outsourcing and Contracting Services

  • API
  • Contract Research
  • Clinical Research
  • C(D)MO
  • Drug Delivery
  • Filling & Packaging
  • Lab Services
  • Logistics Services
  • Reg./Quality Consulting
  • Sales/Marketing

Pharma, Biotech and Life Sciences Product Business

  • Biotech
  • Branded Pharma
  • Generics
  • Nutraceuticals
  • Other Life Sciences

We, repeatedly, have been working withVinc Advisory as they are a real expert consulting organization for the pharmaand pharma services industry – and with them combining extensive corporatefinance know-how with a strong track record and access to all necessaryfunctional experts in assessing business opportunities, they are able toprovide preeminent advice for making our investment decisions. Beyondtransaction tactics and deal structuring, they have been supporting us inquickly gaining a comprehensive understanding of business models, quality oftechnological and service offerings, uncovering hidden value potentials as wellas potential risk factors from a financial, operational and strategic point ofview. They have been a great sparring partner in various M&A projects andit has been always a pleasure working with the Vinc team.

Frank Rotmann
Co-Founder - pharma&, CH

We experienced Vinc as extremely knowledgeable and professional. When it comes to Life Sciences, their deep sector expertise and global network is a real asset and unusually broad for an M&A firm of their size; we were positively surprised. They also did a great job for the sellers where they had to manage conflicting interests of various parties involved within a very short time period. We look forward to working with them in the future.

Alexander Zamora
Partner - Capiton, DE

We were very pleased with the support from Vinc during the entire process of the sale of our business. We really welcome the opportunity of the GBA Laboratory Group moving the company forward to the next stages of its growth. Vinc has done a great job. Many thanks for getting what we believe was the best outcome of this transaction.

Dr. Christine Batzl-Hartmann
CEO and founder - Pharmacelsus, DE

I would like to truly express my appreciation for VINC Advisory. They provided invaluable support in helping to position the company for future growth and opportunities, increasing value for its shareholders.
Throughout their outstanding experience in the life science and health care sectors they provided keen counsel and identification in the market of the most suitable technology and industrial partner that shall help the company to achieve its ambitious goals and further increase its value.

Head of Engineering
Multinational Pharmaceutical/Biotech Company, EU

The Vinc Team has been one of the very few amongst the advisory firms to demonstrate an intimate understanding of our CDMO industry, thus clearly standing out. Their expertise is clear and precious and their approach is professional and pragmatic, clearly going the extra mile to bring value.

Head of Corporate Development
Top 10 Drug Product CDMO, EU

Holistic partner on your Road-to-Exit

Vinc Growth

Created for start-ups and growth ventures, Vinc Growth as the right partner covering the specific areas tailored to each case for a successful journey.

We have experienced Vinc as a very skilled partner who advised and guided us during the entire process of the sale of our business. They have helped us in many ways, from supporting the company presentation and positioning, to closing the contracts. Our sincere appreciation to the dedicated team for their integrity, professionalism and persistence. Vinc did an excellent job. Thank you for getting what we think was the best outcome of this transaction.

Johan Klootwijk
CEO and Co-Founder - Inno4Life, NL

We want to thank Vinc for their great support on our growth financing and were impressed by their strong financial advisory expertise they showed, combined with their comprehensive network of capital partners across all classes (Private Equity, Mezzanine, Debt). We highly appreciated their full service in the execution of the set-up of our platform from the development of the business case, creation of the investor presentation and preparing us for the investors talks.

Elmar Zagler
Co-Founder - pharma&, AT

Dedicated Advisory Team focussed exclusively on the Life Sciences industry


Our Team has extensive deal-making experience, deep sector knowledge and strong personal relationships with the key decision makers in the Life Sciences industry. Combined with our passion, dedication and determination we’re able to provide a particular value-add for your project and/or transaction.

Manfred Stadler

Manfred Stadler

General  Transaction & Financial Advisory Lead

Manfred has M&A, Management, Finance and Controlling expertise; Life Sciences and API Experience in Corporate Strategy and M&A, Head of BD and CFO roles. He has lived and worked in various countries (US, UK, CH, D, A) and industries (Pharma, Chemical, Communications) and gathered both, management and consulting  experience and skills. His deep understanding of the industry, of valuing and integrating businesses, makes him a valuable partner in transaction and transformation processes.

Previously:  Kybora, Cambrex, Lonza, DDB, Mobil Oil

Thomas Kern
Founder and Managing Partner

Thomas Kern

Founder and Managing Partner
General  Transaction & Financial Advisory Lead

Thomas is a successful life science corporate finance advisor, capital sourcing expert, investor and mentor. With his large network and long-standing experience in working with Life Sciences companies he’s a trusted partner to his clients. Building bridges between company owners and investors, constructing compelling equity stories, deal moderation and negotiation are his speciality.

Previously: Citi, Deutsche Bank, MP Corporate Finance

Stephan Freudl

Stephan Freudl

General  Transaction & Financial Advisory Lead

Stephan  is a successful investor, advisor and mentor, strongly rooted within the Life Sciences industry. He is also Co-Founder of VINC Growth. His clients and ventures benefit both, from his large network and long-standing experience gained in numerous transactions and investments. Developing and executing the right “Road-to- EXIT” strategy, growth financing & capital sourcing and structuring business models are his speciality.

Previously: Deutsche Bank, LonVin Partners (Founder), SEF Opportunities Group (Founder)

Giuseppe Cassisi

Giuseppe Cassisi

General  Transaction & Financial Advisory Lead

Giuseppe has substantial experience in top level strategic management positions in the Life Science industry. He excells in sales and business development, as well as global business management. He gained his extraordinary skills in the domestic (Italian) and international markets. Giuseppe combines a deep understanding of the Life Sciences industry with a deep understanding and vision on how the industry will evolve.

Previously:  Polpharma, Doppel Farmaceutici, Patheon, Pharmatec Int'l

Jon Nighswander

Jon Nighswander

General  Transaction & Financial Advisory Lead

Jon is a successful executive, investor, and advisor with a global track record of  achievement in the medical device industry. He has led numerous organizations “from good to great” and has extensive experience both, sourcing and closing transactions. Jon specializes in special situations, valuations, corporate transformation, post-merger  integration and transaction support.

Previously:  PwC, FTI, EMSA Capital, Schottentor Capital (Founder)

Dietmar Hofstätter

Dietmar Hofstätter

General  Transaction & Financial Advisory Lead

Dietmar is an independent consultant in the life science sector, specialized in in- and out-licensing, as well as business and corporate development. With his extensive top-level management experience, he has a extremely wide network in virtually every country of the world. Combining his  PhD in law with in-depth pharmaceutical knowledge, Dietmar excels in transforming business models with well balanced, workable and understandable contracts.

Previously:  Asta Medica (now: Mylan), Lederle (now: Pfizer), Sandoz

Hervé Mouneyrac

Hervé Mouneyrac

General  Transaction & Financial Advisory Lead

Hervé has extensive CDMO expertise, with particular focus on strategy and value creation, corporate acquisition and integration processes, as well as business development and cost reduction initiatives. He has had a transforming impact in CDMO on an international scale. With his creative and pragmatic problem solving skills he generates competitive advantage for his clients, defining a vision and aligning the organization to deliver it, thanks to his deep understanding of the industry.

Previously:  Famar, Masai, Renault

Claudia Vogt
Admin Assistant

Claudia Vogt

Admin Assistant
General  Transaction & Financial Advisory Lead

Claudia  handles office management to free the partners from administrative details. With her experience in hospitality industry and event management, as well as logistics she juggles various tasks. Administration with a smile.

Previously:  Hospitality Insustry and event management, Bosch

Get in touch with us


We like to listen and to understand. And we’re happy to discuss your specific case and to share our ideas – hands-on, pragmatic, concise. Here’s how you can reach us:

VINC Advisory GmbH
Life Sciences Strategic Transaction Advisory
Rathausstrasse 11
1010 Vienna, Austria

+43 1 361 66 63-0

Legal info
Privacy policy